Cord Blood Stem Cells

A report identifies the main technical procedures currently used by public cord blood banks worldwide

Researchers report a crucial role for mTOR in cell‐cycle progression and proliferation in the commitment/proliferation phase of erythropoiesis 

For the past 30 years, umbilical cord blood has been a viable graft source option for hematopoietic cell transplant for both pediatric and adult patients with hematologic disorders.

The limited numbers of cord blood hematopoietic stem cells (HSCs) collected at birth remains a critical limiting factor in the use of cord blood for HSC transplantation.

A new STEM CELLS Translational Medicine article from researchers led by

A recent STEM CELLS article from researchers led by

An exciting new STEM CELLS Translational Medicine article from the laboratories of Scott D. Olson and Charles S.

Trial provides evidence for the safety and feasibility of cord blood cell infusion after birth in preterm neonates to reduce the rate of complications

Successful pre‐clinical studies in animal models heralded the increasing clinical interest of cord blood in regenerative therapy.

A recent STEM CELLS Translational Medicine article reporting on a prospective non-r